143 related articles for article (PubMed ID: 11726142)
21. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.
van Setten PA; Monnens LA; Verstraten RG; van den Heuvel LP; van Hinsbergh VW
Blood; 1996 Jul; 88(1):174-83. PubMed ID: 8704172
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.
Kehl KS; Havens P; Behnke CE; Acheson DW
J Clin Microbiol; 1997 Aug; 35(8):2051-4. PubMed ID: 9230380
[TBL] [Abstract][Full Text] [Related]
23. Infection by verocytotoxin-producing Escherichia coli.
Karmali MA
Clin Microbiol Rev; 1989 Jan; 2(1):15-38. PubMed ID: 2644022
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
25. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
Isogai E; Isogai H; Kimura K; Hayashi S; Kubota T; Fujii N; Takeshi K
Infect Immun; 1998 Jan; 66(1):197-202. PubMed ID: 9423858
[TBL] [Abstract][Full Text] [Related]
26. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.
Malyukova I; Murray KF; Zhu C; Boedeker E; Kane A; Patterson K; Peterson JR; Donowitz M; Kovbasnjuk O
Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G78-92. PubMed ID: 18974311
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome.
Proulx F; Turgeon JP; Litalien C; Mariscalco MM; Robitaille P; Seidman E
Pediatr Infect Dis J; 1998 Oct; 17(10):899-904. PubMed ID: 9802632
[TBL] [Abstract][Full Text] [Related]
28. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.
Takahashi K; Funata N; Ikuta F; Sato S
J Neuroinflammation; 2008 Mar; 5():11. PubMed ID: 18355415
[TBL] [Abstract][Full Text] [Related]
29. Host inflammatory response inhibits Escherichia coli O157:H7 adhesion to gut epithelium through augmentation of mucin expression.
Xue Y; Zhang H; Wang H; Hu J; Du M; Zhu MJ
Infect Immun; 2014 May; 82(5):1921-30. PubMed ID: 24566630
[TBL] [Abstract][Full Text] [Related]
30. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Cell Cycle and Induction of Apoptosis by Shiga-like Toxin Produced by Escherichia coli O157:H7 in T47D Breast Cancer Cells Using Flow Cytometry.
Suardana IW; Swacita IBN; Pinatih KJP; Suharsono H; Widiasih DA
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3247-3252. PubMed ID: 36308345
[TBL] [Abstract][Full Text] [Related]
32. Shiga toxin-producing Escherichia coli (STEC) O22:H8 isolated from cattle reduces E. coli O157:H7 adherence in vitro and in vivo.
Martorelli L; Albanese A; Vilte D; Cantet R; Bentancor A; Zolezzi G; Chinen I; Ibarra C; Rivas M; Mercado EC; Cataldi A
Vet Microbiol; 2017 Sep; 208():8-17. PubMed ID: 28888654
[TBL] [Abstract][Full Text] [Related]
33. Outer membranes are competitive inhibitors of Escherichia coli O157:H7 adherence to epithelial cells.
Sherman P; Cockerill F; Soni R; Brunton J
Infect Immun; 1991 Mar; 59(3):890-9. PubMed ID: 1671778
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, quantification and isolation of pathogenic shiga toxin Escherichia coli O157:H7 along the production and supply chain of pork around Hubei Province of China.
Khan SB; Zou G; Xiao R; Cheng Y; Rehman ZU; Ali S; Memon AM; Fahad S; Ahmad I; Zhou R
Microb Pathog; 2018 Feb; 115():93-99. PubMed ID: 29273508
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
36. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.
Asahara T; Shimizu K; Nomoto K; Hamabata T; Ozawa A; Takeda Y
Infect Immun; 2004 Apr; 72(4):2240-7. PubMed ID: 15039348
[TBL] [Abstract][Full Text] [Related]
37. Loss of O157 O antigenicity of verotoxin-producing Escherichia coli O157:H7 surviving under starvation conditions.
Hara-Kudo Y; Miyahara M; Kumagai S
Appl Environ Microbiol; 2000 Dec; 66(12):5540-3. PubMed ID: 11097947
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Kurioka T; Yunou Y; Harada H; Kita E
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):561-71. PubMed ID: 10517193
[TBL] [Abstract][Full Text] [Related]
39. Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli.
Cilmi SA; Karalius BJ; Choy W; Smith RN; Butterton JR
J Infect Dis; 2006 Oct; 194(8):1135-40. PubMed ID: 16991089
[TBL] [Abstract][Full Text] [Related]
40. Immune-stimulating properties of 80% methanolic extract of Ludwigia octovalvis against Shiga toxin-producing E. coli O157:H7 in Balb/c mice following experimental infection.
Kadum Yakob H; Manaf Uyub A; Fariza Sulaiman S
J Ethnopharmacol; 2015 Aug; 172():30-7. PubMed ID: 26091966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
